GenFleet Therapeutics (Australia) Pty Ltd. clinical trials
A country office of Genfleet Therapeutics (Shanghai) Inc.
The registry lists 1 studies whose lead sponsor is GenFleet Therapeutics (Australia) Pty Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 15, 2023.
- 1study on the registry
- 0open to participants now
What it is testing
The drugs GenFleet Therapeutics (Australia) Pty Ltd.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Over the years
- 121
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- GenFleet Therapeutics (Australia) Pty Ltd.1 study
Something wrong with this grouping? Tell us on the Genfleet Therapeutics (Shanghai) Inc. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Genfleet Therapeutics (Shanghai) Inc. studies →
- A Study of GFH312 in Healthy SubjectsCompletedNCT04676711Phase 1
Sponsor listed in the registry: GenFleet Therapeutics (Australia) Pty Ltd.